BioHarvest Sciences Inc (BHST) - Long-Term Debt to Capital Coefficient

BioHarvest Sciences (BHST) has developed an advanced plant cell cultivation system in bioreactors, positioning the company as a leader in sustainable dietary supplement production. The company is currently scaling its platform, focusing on the US market, B2B deals, and the discovery of therapeutic molecules. Thanks to Bio-Farming, the business possesses strong pricing power, and the metric stands at 0.67. The share price illustrated below reflects the price action of this innovative player.

Conservative capital demands absolute transparency of the liability structure to assess business resilience to external shocks. This indicator measures the share of long-term loans relative to the company's market value, determining the degree of financial leverage and the risk of insolvency. Amid high expansion costs and regulatory barriers in the EU, the long-term debt-to-equity chart for BHST reflects the ability of BioHarvest Sciences to finance the scaling of biosynthesis without a critical debt burden.